Plasma betacarotene in Alzheimer's disease. Association with cerebrospinal fluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau

Neuroendocrinology Letters

Volumn 26, Issue 6, 2005, Pages 696-698

  Stuerenburg, Hans Joerg ^a   Ganzer, Stefanie ^b   Müller Thomsen, Tomas ^b,c  

^a MEDIAN Kliniken GmbH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Psychiatric Clinic Haecklingen   (Germany)

Author keywords

Alzheimer's disease; Anti amyloidogenic; Beta amyloid 1 40; Beta amyloid 1 42; Cerebrospinal fluid; Diet; MMSE; Plasma betacarotene; Total Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E4; BETA CAROTENE; CHOLINESTERASE INHIBITOR; NEUROLEPTIC AGENT; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN CEREBROSPINAL FLUID LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; BLOOD; CEREBROSPINAL FLUID; CLINICAL TRIAL; COMPARATIVE STUDY; MULTIVARIATE ANALYSIS;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BETA CAROTENE; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 33645005344     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Ganzer S, Arlt S, Schoder V, Buhmann C, Mandelkow EM, Finckh U, Beisiegel U, Naber D, Muller-Thomsen T. CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity. J Neural Transm 2003; 110 (10):1149-60.
2. Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK, Elkenberg O, Antz C, Krause WR, Reulbach U, Kornhuber J, Wiltfang J. Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/ Abeta40 ratio and total tau. Neuroblol Aging 2004; 25 (3):273-81
3. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M. Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro. Neurol 2004; 189(2):380-92.
4. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M. Potent anti-amyloidogenic and fibril-destabilizimg effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem 2003,87(1):172-81.
5. Stuerenburg HJ, Ganzer S, Muller-Thomsen T. 5-hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer″s disease, depression and mild cognitive impairment. Neuroendocrinol Lett 2004 Dec; 25(6):435-7
6. Stuerenburg HJ, Mueller-Thomsen T., Methner A. Vitamin B 12 plasma levels in Alzheimer's disease. Neuroendocrinol Lett 2004 Jun; 25(3):176-7.
7. Stuerenburg HJ, Ganzer S, Arlt S, Muller-Thomsen T. The influence of smoking on plasma folate and lipoproteins in Alzheimer disease, mild cognitive impairment and depression. Neuroendocrinol Lett 2005 Jun; 26(3):261-3.